Schizophrenia

1 stories about Schizophrenia
בניין חברת טבע כפר סבא

Teva gets FDA green light for second long-acting schizophrenia drug

09.10.26|CTech
Weltruza follows the 2023 approval of Uzedy, extending Teva's partnership with France's Medincell as it seeks to build new sources of branded drug revenue.